Search
for
Sort by
Research 331–360 of 334
- Optimization of polyphenol extraction from Eclipta prostrata L. by response surface methodology
- MSC-derived exosomes protect auditory hair cells from neomycin-induced damage via autophagy regulation
- Reconstruction of Scalp and Forehead Defects: Options and Strategies
- Myc and Fgf Are Required for Zebrafish Neuromast Hair Cell Regeneration
- Potential role and therapeutic interests of myo-inositol in metabolic diseases
- Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome
- Metabolic and hormonal effects of a combined Myo-inositol and d-chiro-inositol therapy on patients with polycystic ovary syndrome (PCOS)
- Update on the combination of myo-inositol/d-chiro-inositol for the treatment of polycystic ovary syndrome
- Myo-inositol in polycystic ovary syndrome: a systematic review and positioning of its use
- Role of Myo-inositol and D-Chiro-Inositol in Improvement of Endocrine and Clinical Parameters in Girls affected by PCOS
- Myo-Inositol for Cutaneous Manifestations of Polycystic Ovary Syndrome: An International Delphi Consensus Recommendation for Dermatology Practice
- Association of Myo-Inositol and Microlipodispersed Magnesium in Androgen-Dependent Dermatological Diseases: A Retrospective Study
- Myo-Inositol (ProFecund Ino) – Obtaining a Pregnancy in Women with Polycystic Ovary Syndrome
- Comparing the Efficacy of Myo-Inositol Plus α-Lactalbumin vs. Myo-Inositol Alone on Reproductive and Metabolic Disturbances of Polycystic Ovary Syndrome
- Effect of Metformin and Myo-inositol in Patients with Polycystic Ovary Syndrome
- Myo-Inositol to D-Chiro-Inositol ratio in follicular fluid plays a pivotal role for oocyte and embryo quality: summary of available evidence
- Study of effect of myoinositol on menstrual irregularities and skin problems in polycystic ovarian syndrome cases
- Evaluating combined therapy with myoinositol and D-chiro-inositol in infertility management across PCOS phenotypes: a comprehensive retrospective data analysis
- Use of Myoinositol in PCOS
- Does <i>myo</i>-inositol oxygenase, the only enzyme to catalyze <i>myo</i>-inositol <i>in vivo</i>, play a role in the etiology of polycystic ovarian syndrome?
- Therapeutic potential of inositol to PCOS: An overview of administration, efficacy, and potential applications
- Inositol versus Metformin administration in polycystic ovary syndrome patients
- Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women
- Nutrition Strategy and Life Style in Polycystic Ovary Syndrome—Narrative Review
- Efficacy and Safety of Tracnil™ Administration in Patients with Dermatological Manifestations of PCOS: An Open-Label Single-Arm Study
- New Perspectives on Nutraceutical Insulin Sensitizing Agents in the Treatment of Psoriasis and Other Dermatological Diseases
- Recomendations on non-pharmacological interventions in women with PCOS to reduce body weight and improve metabolic disorders [Zalecenia dotyczące postępowania niefarmakologicznego u kobiet z PCOS celem zmniejszenia masy ciała i poprawy zaburzeń metabolicznych]
- Functional Ingredient Mapping in PCOS Formulations: Hormonal Excess
- Study on Women with Polycystic Ovary Syndrome and their Health-Related Quality-Of-Life by Confirmatory Analysis
- Management of Polycystic Ovarian Syndrome: Looking Beyond the Ovaries